澳大利亚妊娠期糖尿病后母亲糖尿病预防计划（MAGDA-DPP）产后干预：一项随机对照试验研究方案的更新
Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: an update to the study protocol for a randomized controlled trial.
作者信息
Shih Sophy T F, Davis-Lameloise Nathalie, Janus Edward D, Wildey Carol, Versace Vincent L, Hagger Virginia, Asproloupos Dino, O'Reilly Sharleen L, Phillips Paddy A, Ackland Michael, Skinner Timothy, Oats Jeremy, Carter Rob, Best James D, Dunbar James A
机构信息
Greater Green Triangle University Department of Rural Health, Flinders University, PO Box 423, 3280 Warrnambool, VIC, Australia.
出版信息
Trials. 2014 Jun 30;15:259. doi: 10.1186/1745-6215-15-259.
BACKGROUND
The Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) is a randomized controlled trial (RCT) that aims to assess the effectiveness of a structured diabetes prevention intervention for women who had gestational diabetes.
METHODS/DESIGN: The original protocol was published in Trials (http://www.trialsjournal.com/content/14/1/339). This update reports on an additional exclusion criterion and change in first eligibility screening to provide greater clarity. The new exclusion criterion "surgical or medical intervention to treat obesity" has been added to the original protocol. The risks of developing diabetes will be affected by any medical or surgical intervention as its impact on obesity will alter the outcomes being assessed by MAGDA-DPP. The screening procedures have also been updated to reflect the current recruitment operation. The first eligibility screening is now taking place either during or after pregnancy, depending on recruitment strategy.
TRIAL REGISTRATION
Australian New Zealand Clinical Trials Registry ANZCTRN 12610000338066.
背景
澳大利亚妊娠糖尿病后母亲糖尿病预防项目（MAGDA-DPP）是一项随机对照试验（RCT），旨在评估针对患有妊娠糖尿病的女性进行结构化糖尿病预防干预的有效性。
试验注册
澳大利亚新西兰临床试验注册中心ANZCTRN 12610000338066。
Zotero 插件